What the current human evidence actually shows
The strongest human evidence for postbiotics comes from a 2025 randomized, double-blind, placebo-controlled crossover trial in 110 adults with chronic constipation [4]. After just 3 weeks of taking the postbiotic Probio-Eco, participants reported significant improvements in constipation symptoms, stool straining, and worry scores. The study also measured changes in gut bacteria and metabolites like butyrate and propionate that correlated with symptom relief. This is the largest and most rigorous human trial among the papers here, and it shows a clear short-term benefit.
For oral health, a 2024 randomized controlled trial in 31 people found that using a postbiotic toothpaste for an unspecified period (likely weeks) significantly raised salivary IgA (an immune marker) and increased levels of beneficial short-chain fatty acids like acetic and propionic acid [1]. These changes persisted even 1 month after stopping the toothpaste. The postbiotic also reduced the abundance of harmful bacteria like Klebsiella and Escherichia without disrupting the overall mouth microbiome. A separate 2025 double-blind trial in 24 dogs showed a 22% reduction in volatile sulfur compounds (the cause of bad breath) after just 7 days of a postbiotic powder [2].
Together, these studies suggest postbiotics can produce measurable benefits in the short term (days to weeks) for gut and oral health, with effects that may outlast the treatment period. But none of these trials followed participants for more than a few weeks, so we cannot yet speak to long-term effects.
The big gaps: long-term safety, metabolic effects, and mental health
The most important gap is the complete absence of long-term human trials. The longest intervention in these papers was 3 weeks [4]. We don't know if benefits persist, fade, or reverse over months or years, nor whether long-term use carries any risks. A 2024 review paper [5] explicitly states that 'further studies and efforts are needed to evaluate and describe new postbiotics' and that their effects on metabolic disorders and immune modulation 'need to be investigated in the future.' This is a call for more research, not a conclusion of proven long-term safety.
Another major unknown is whether postbiotics can help with metabolic or psychiatric conditions. A 2025 protocol for a double-blind trial in first-episode psychosis and schizophrenia patients [3] aims to test whether a postbiotic added to antipsychotic drugs can prevent metabolic disturbances like weight gain and insulin resistance. The authors note that probiotics have shown some benefit, and postbiotics may offer 'higher beneficial effects and lower risk.' But this trial is still underway — no results are available. So for now, any claims about postbiotics improving mental health or metabolic syndrome remain speculative.
Finally, the evidence base is still small. Only two of the five papers here are completed human trials [1][4], and one of those is in dogs [2]. The review [5] and the protocol [3] add context but not new data. So while the early signals are encouraging, the field is in its infancy, and long-term human evidence is simply not there yet.
What should you do with this information?
If you're considering a postbiotic supplement for constipation or oral health, the short-term human data is reasonably supportive. The 2025 constipation trial [4] used a specific product (Probio-Eco) and showed clear benefits in 3 weeks. The 2024 oral health trial [1] used a toothpaste with inactivated Lactobacillus strains and showed immune and microbiome improvements. Both were randomized, double-blind, and placebo-controlled — the gold standard for clinical evidence.
However, because long-term data is absent, it would be wise to treat postbiotics as a short-term tool rather than a lifelong therapy until more evidence emerges. If you have a chronic condition like schizophrenia or metabolic syndrome, wait for the results of ongoing trials [3] before expecting benefits. And always consult a healthcare provider before starting any new supplement, especially if you are on medication.
In summary: the evidence says 'promising but provisional.' Postbiotics appear safe and effective in the short term for specific uses, but we need years-long human studies to know if they hold up over time.
About These Sources
This answer is built on 5 peer-reviewed studies — published from 2024 to 2025, 5 from 2024 or later, 4 in Q1 journals, collectively cited 76 times — selected as the most relevant from 5 studies that passed quality screening, drawn from 53 papers retrieved from a database of over 500 million.
Sources used in this answer
Evaluating the Role of Postbiotics in the Modulation of Human Oral Microbiota: A Randomized Controlled Clinical Trial
In a randomized controlled trial of 31 people, a postbiotic toothpaste significantly increased salivary IgA and short-chain fatty acids (acetic and propionic acid) and reduced harmful oral bacteria like Klebsiella and Escherichia, with effects persisting 1 month after stopping.
A Novel Postbiotic Reduces Canine Halitosis
In a double-blind, placebo-controlled trial of 24 dogs, a postbiotic powder reduced volatile sulfur compounds (bad breath) by 22% after 7 days and by 27% overall compared to placebo.
The effectiveness of an add-on postbiotic to antipsychotic drugs for prevention of metabolic disturbances in patients with first-episode psychosis and schizophrenia spectrum disorder. A double blind clinical trial
This is a protocol for an ongoing double-blind trial testing whether a postbiotic added to antipsychotic drugs can prevent metabolic disturbances in first-episode psychosis and schizophrenia patients; no results are yet available.
Efficacy of a postbiotic and its components in promoting colonic transit and alleviating chronic constipation in humans and mice.
In a randomized, double-blind, placebo-controlled crossover trial of 110 adults with chronic constipation, 3 weeks of the postbiotic Probio-Eco significantly improved constipation symptoms, stool straining, and worry scores, with changes in gut microbiota and metabolites like butyrate and propionate.
Postbiotics as Metabolites and Their Biotherapeutic Potential
This review highlights the therapeutic potential of postbiotics for metabolic disorders and immune modulation but explicitly calls for more research, noting that long-term human studies are still needed.
